. 2019 Dec 15;55(12):784. doi: 10.3390/medicina55120784

Table 3.

Analysis of correlations between the plasma levels of SCL and IL-6 within the study group and the control group and the body weight, BMI, and waist circumference of subjects (R—correlation coefficient).

Parameter		Sclerostin						Interleukin 6
		Study Group (n = 34)			Control Group (n = 31)			Study Group (n = 34)			Control Group (n = 31)
		E0	E3	E6	E0	E3	E6	E0	E3	E6	E0	E3	E6
Body weight [kg]	R	−0.10	−0.07	−0.01	0.26	0.36	0.26	0.03	0.05	0.03	0.25	0.36	0.49
Body weight [kg]	p-value	0.5723	0.6637	0.9781	0.1564	0.0443 *	0.1544	0.8529	0.7546	0.8651	0.1687	0.0480 *	0.0043 *
BMI [kg/m²]	R	−0.14	−0.16	−0.13	0.27	0.43	0.29	−0.06	−0.06	−0.07	0.33	0.46	0.53
BMI [kg/m²]	p-value	0.4560	0.3478	0.4774	0.1279	0.0156 *	0.1168	0.7254	0.7281	0.6745	0.0689	0.0097 *	0.0021 *
Waist circumference [cm]	R	−0.20	−0.07	−0.10	0.45	0.49	0.44	0.12	0.08	0.11	0.27	0.54	0.50
Waist circumference [cm]	p-value	0.2652	0.6856	0.5637	0.0106 *	0.0049 *	0.0112*	0.4949	0.6131	0.5452	0.1362	0.0016 *	0.0039 *
Hip circumference [cm]	R	−0.29	−0.27	−0.19	0.21	0.35	0.26	−0.03	−0.12	−0.17	0.24	0.52	0.41
Hip circumference [cm]	p-value	0.0854	0.1178	0.2789	0.2571	0.0522	0.1500	0.8546	0.4753	0.3331	0.1800	0.0025 *	0.0188 *
WHR	R	0.09	0.18	0.03	0.53	0.52	0.47	0.20	0.16	0.32	0.25	0.45	0.42
WHR	p-value	0.960	0.2843	0.8442	0.0018 *	0.0026 *	0.0068 *	0.2526	0.3380	0.0574	0.1678	0.0099 *	0.0165 *

E0—measurement at study entry; E3—measurement after 3 months of study; E6—measurement after 6 months of study; R—correlation coefficient; p-value—statistical significance; *—statistically significant parameter; BMI—body mass index; WHR—waist hip ratio; n—number.